Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04870320 · ClinicalTrials.gov registry record · NA
Study of Attention and Memory Treatments for Cancer Survivors
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT04870320: Completed NA study, sponsored by University of California, San Francisco.
NCT04870320 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 49 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04870320, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
This clinical trial investigates if certain electronic games may be effective in improving attention and memory function in cancer survivors. Cancer related cognitive impairment (CRCI) is an issue experienced by many cancer patients/survivors. CRCI includes perceived or objective problems with memory, executive function, and attention/concentration. CRCI has a negative impact on survivors' ability to work, carry out routine activities, and engage in social and family relationships. CRCI may result in significant distress and reduced quality of life. Certain electronic games may help improve attention and memory function in cancer survivors and reduce symptoms of CRCI.
Primary Outcome
Completion is defined as participants who completed all 4 weeks of intervention and final assessment.
Interventions
- OTHER Quality of Life (QOL) Questionnaires
- BEHAVIORAL Endeavor: Computer-Based Cognitive Stimulation Intervention
- BEHAVIORAL Words!: Computer-Based Cognitive Stimulation Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2022-01-31 |
| Phase | NA |
What the finished NCT04870320 record still lists
NCT04870320 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Quality of Life (QOL) Questionnaires is the first listed.
NCT04870320 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04870320 about?
NCT04870320 is a clinical study titled "Study of Attention and Memory Treatments for Cancer Survivors". This clinical trial investigates if certain electronic games may be effective in improving attention and memory function in cancer survivors. Cancer related cognitive impairment (CRCI) is an issue experienced by many cancer patients/survivors. CRCI includes perceived or objective problems with memor...
What is the current status of trial NCT04870320?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2021-03-01. Estimated completion is 2022-01-31.
What interventions are being tested in trial NCT04870320?
The interventions under investigation include: Quality of Life (QOL) Questionnaires (OTHER), Endeavor: Computer-Based Cognitive Stimulation Intervention (BEHAVIORAL), Words!: Computer-Based Cognitive Stimulation Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04870320?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04870320's enrollment target sits among peer trials
49 1379th of 2000 higher than 620 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI